SEC Form 4 · accession 0001209191-16-144723
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark McDade
Director
Period of report
Oct 3, 2016
Accepted (ET)
Oct 4, 2016 · 7:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 3, 2016 | M | 10,162 | $1.23 | A | 10,162 | D | |
| Common Stock | Oct 3, 2016 | M | 2,439 | $1.85 | A | 12,601 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.23 | Oct 3, 2016 | M | 10,162 | D | — | Oct 26, 2016 | Common Stock | 10,162 | 0 | D |
| Stock Option (right to buy)F1 | $1.85 | Oct 3, 2016 | M | 2,439 | D | — | Jul 26, 2017 | Common Stock | 2,439 | 0 | D |
Explanation of responses
- F1This option was fully vested and immediately exercisable.